ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
Clinical trials for ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to beat Hard-to-Treat leukemia
Disease control OngoingThis phase 2 trial is testing a combination of two drugs—CPX-351 (a chemotherapy) and glasdegib (a targeted pill)—in 30 people with acute myeloid leukemia (AML) that is either linked to a prior blood disorder or caused by previous cancer treatment. The main goal is to see how man…
Matched conditions: ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Experimental drug combo shows promise for Tough-to-Treat leukemia
Disease control OngoingThis study tests whether adding pevonedistat to standard chemotherapy (cytarabine and idarubicin) can improve remission rates in people newly diagnosed with high-risk acute myeloid leukemia (AML). About 53 participants will receive the combination to find the best dose and check …
Matched conditions: ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug combo shows promise for Tough-to-Treat leukemia in younger patients
Disease control OngoingThis study tests a chemotherapy drug called CPX-351 in people under 60 with secondary acute myeloid leukemia (AML), a type of leukemia that develops after other blood disorders or cancer treatments. The goal is to see how well the drug can make the cancer disappear or improve blo…
Matched conditions: ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA-RELATED CHANGES
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC